188 related articles for article (PubMed ID: 32089219)
1. Treatment of Acquired Sideroblastic Anemias.
Mangaonkar AA; Patnaik MM
Hematol Oncol Clin North Am; 2020 Apr; 34(2):401-420. PubMed ID: 32089219
[TBL] [Abstract][Full Text] [Related]
2. Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ; Calvo X; Arenillas L
Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140729
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management".
Patnaik MM; Tefferi A
Am J Hematol; 2021 Mar; 96(3):379-394. PubMed ID: 33428785
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M; Malcovati L
Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
[TBL] [Abstract][Full Text] [Related]
5. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts.
Malcovati L; Cazzola M
Br J Haematol; 2016 Sep; 174(6):847-58. PubMed ID: 27391606
[TBL] [Abstract][Full Text] [Related]
7. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".
Patnaik MM; Tefferi A
Am J Hematol; 2019 Apr; 94(4):475-488. PubMed ID: 30618061
[TBL] [Abstract][Full Text] [Related]
8. SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis.
Zhu Y; Li X; Chang C; Xu F; He Q; Guo J; Tao Y; Liu Y; Liu L; Shi W
Leuk Res; 2016 May; 44():8-16. PubMed ID: 26970172
[TBL] [Abstract][Full Text] [Related]
9. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
10. [Ring sideroblasts and iron metabolism].
Fujiwara T
Rinsho Ketsueki; 2020; 61(7):770-778. PubMed ID: 32759564
[TBL] [Abstract][Full Text] [Related]
11. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
Malcovati L; Karimi M; Papaemmanuil E; Ambaglio I; Jädersten M; Jansson M; Elena C; Gallì A; Walldin G; Della Porta MG; Raaschou-Jensen K; Travaglino E; Kallenbach K; Pietra D; Ljungström V; Conte S; Boveri E; Invernizzi R; Rosenquist R; Campbell PJ; Cazzola M; Hellström Lindberg E
Blood; 2015 Jul; 126(2):233-41. PubMed ID: 25957392
[TBL] [Abstract][Full Text] [Related]
12. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.
Chen Z; Wang SA; Goswami M; Tang G; Routbort MJ; Patel KP; Luthra R; Medeiros LJ; Ok CY
Leuk Res; 2019 Nov; 86():106227. PubMed ID: 31557598
[TBL] [Abstract][Full Text] [Related]
13. [Biology of sideroblastic anemia].
Harigae H
Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
[TBL] [Abstract][Full Text] [Related]
14. Sideroblastic anemia: diagnosis and management.
Bottomley SS; Fleming MD
Hematol Oncol Clin North Am; 2014 Aug; 28(4):653-70, v. PubMed ID: 25064706
[TBL] [Abstract][Full Text] [Related]
15. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess].
Meng FK; Huang LF; Zhou JF; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).
Ohba R; Furuyama K; Yoshida K; Fujiwara T; Fukuhara N; Onishi Y; Manabe A; Ito E; Ozawa K; Kojima S; Ogawa S; Harigae H
Ann Hematol; 2013 Jan; 92(1):1-9. PubMed ID: 22983749
[TBL] [Abstract][Full Text] [Related]
17. Ineffective erythropoiesis and its treatment.
Cazzola M
Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in the knowledge of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2022; 63(6):600-607. PubMed ID: 35831194
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial iron metabolism and sideroblastic anemia.
Sheftel AD; Richardson DR; Prchal J; Ponka P
Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
[TBL] [Abstract][Full Text] [Related]
20. [Molecular pathophysiology of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
